 |
 |
On Mon, 3 Jun 2002, Mark O Mahony wrote:
> Before I get deluged with criticism, may I say that I forgot to preface my
> remarks by saying that I was concerned mainly with primary prevention, not
> secondary , nor diabetes.
It was a very interesting post. Do you or any one else have similar
reflections on putative/possible efficacy/worthwhileness or not of
ramipril or other ACE inhibitors on lowering of risk of development of
diabetes (primary prevention)?
Regards,
Anne Peticolas
Austin, Texas